You might be reading this after another interrupted outing. You stood up from a café chair and felt that familiar worry. You mapped the closest toilet before leaving home. You packed pads in your bag again, even though you hoped you wouldn't need them. For many people, bladder leakage isn't just a symptom. It changes confidence, planning, sleep, intimacy, exercise, and how long you feel safe being away from home.
That's especially true when continence issues sit alongside other pressures. Ageing, reduced mobility, disability, caring responsibilities, menopause, childbirth recovery, chronic illness, or a rushed morning routine can all make a bladder problem feel bigger than it sounds on paper. In clinic, people often say the same thing in different words: “I just want to feel in control again.”
One option that's getting a lot of attention is Emsella chair treatment. It's a seated, non-invasive pelvic floor therapy that aims to strengthen the muscles that support bladder control. It can be useful for some people. It can also be oversold. The practical question isn't whether the technology sounds impressive. The practical question is whether it fits your continence problem, your body, your goals, and your broader care plan.
Table of Contents
- Living with Incontinence and Exploring New Options
- How the Emsella Chair Works
- Clinical Evidence and Expected Results
- Determining If You Are a Good Candidate
- The Emsella Treatment Process Explained
- Cost and Funding Considerations in Australia
- Why a Continence Assessment Should Be Your First Step
Living with Incontinence and Exploring New Options
A common pattern in clinic starts gradually. Someone notices a few drops when they cough, laugh, lift the shopping, or stand up after sitting too long. Then they begin planning around the bladder. They choose seats near exits, carry spare pads, avoid long outings, and start drinking less than they should.
For older Australians and many NDIS participants, the problem is rarely just the leakage itself. The bigger issue is what it changes. Confidence drops. Sleep is disrupted. Skin can become irritated. Carers take on more work. Everyday tasks start to feel harder than they should.
People often ask about new treatments when those workarounds stop feeling manageable. That is a reasonable point to start asking questions.
Why people start looking beyond pads
Pads and pull-ups have a clear role. They contain leakage and protect clothing and bedding. They do not address why the leakage is happening.
Other options can help, but each has limits. Bladder training takes consistency. Pelvic floor exercises help many people, but some struggle to contract the right muscles or keep the routine going. Medicines may reduce urgency for some, yet side effects can be a problem, especially in older adults who are already managing dry mouth, constipation, dizziness, or multiple prescriptions. Surgery can be appropriate in selected cases, but it is not the first step for everyone.
That is why chair-based treatments get attention. People want a non-surgical option that feels practical and less confronting. They also want an honest answer about whether it suits their type of incontinence, their mobility, and their wider health picture.
If you're also trying to work out whether your symptoms fit a broader pelvic health pattern, this overview of pelvic conditions treated can help you see how bladder symptoms may overlap with other pelvic floor concerns.
The goal is not to chase a miracle fix. The goal is to match the treatment to the cause, the person, and the setting they live in.
A grounded way to think about Emsella
Emsella can be useful when pelvic floor weakness is contributing to symptoms. That matters for some people with stress incontinence, and for some with mixed symptoms. It may also appeal to people who want to avoid an internal treatment or are not ready to consider surgery.
Still, continence problems are often layered. In older adults, I commonly see leakage linked with constipation, reduced mobility, poor hand function, difficulty transferring to the toilet, prostate enlargement, prolapse, cognitive change, diuretic use, chronic cough, or not getting there in time. In NDIS settings, toileting support, equipment, communication needs, sensory issues, and fatigue can all affect the result.
A chair treatment may improve one part of that picture. It does not correct every contributor.
That is the practical lens to use. Emsella may fit well as one tool in a broader continence plan that also includes assessment, bladder and bowel management, pelvic floor rehab, skin care, equipment review, and support strategies at home or in care.
How the Emsella Chair Works
Emsella uses HIFEM, which stands for high-intensity focused electromagnetic therapy. In plain language, the chair creates a strong electromagnetic field that stimulates the pelvic floor muscles while you sit on it. A peer-reviewed comparative study describes it as a non-invasive HIFEM therapy delivered from a seated chair applicator, with a magnetic field strength of up to 2.5 Tesla, and notes that treatment is performed as an outpatient procedure with no recovery time (peer-reviewed HIFEM study details).
Why the chair format appeals to many people
The appeal is easy to understand. You remain clothed. You sit rather than undress for an internal treatment. There's no incision, no anaesthetic, and no recovery period afterwards. For someone who feels embarrassed about leakage or overwhelmed by the thought of surgery, that lower barrier matters.
The chair also helps people who struggle to isolate pelvic floor contractions correctly. Plenty of people are told to do Kegels, but many aren't confident they can feel the right muscle group or keep up a regular exercise programme.
What HIFEM is doing in simple terms
The simplest analogy is this. Think of Emsella as an automated, high-intensity pelvic floor workout. Instead of relying on you to remember and perform repeated voluntary squeezes, the machine stimulates the muscles directly and causes very strong contractions.
Those contractions are often described as supramaximal, meaning they go beyond what is comfortably achievable through conscious effort alone. The goal is muscle re-education and strengthening. Better muscle support may then improve bladder control in people whose leakage is linked to pelvic floor weakness.
A basic flow looks like this:
- Electromagnetic energy is delivered while you sit in the chair.
- The energy penetrates to the pelvic floor muscles without surgery or needles.
- Motor neurons are stimulated, which triggers repeated muscle contractions.
- The muscles are trained and re-educated, aiming to improve support and control.
Practical rule: Emsella makes the most sense when the treatment target is muscular. It makes less sense when the main problem is functional, neurological, anatomical, or environmental.
That distinction matters. If someone leaks because they can't transfer safely to the toilet, can't undo clothing quickly, has delirium, has severe urgency linked to another condition, or has significant prolapse or retention concerns, the mechanism of the chair may not match the underlying cause of the accidents.
Clinical Evidence and Expected Results
Early research on Emsella is encouraging, but the evidence base is still modest. In practice, that means two things can be true at once. Some people do report worthwhile improvement, and the treatment still needs careful case selection and realistic expectations.
What the published numbers show
One comparative HIFEM study reported that after 10 treatments, the HIFEM group had a mean pelvic floor disability improvement of more than 50%, compared with 18% in the electrostimulation group. The same source also reported that, in a 30-patient study, 95% of treated patients improved quality of life after 6 treatments, 67% eliminated or reduced pad use, and benefits were maintained at 3- and 6-month follow-up (comparative HIFEM outcomes).
Those figures are useful, but they need context.
| Finding | What it may mean clinically |
|---|---|
| Symptoms can improve | Some patients report less leakage and better day-to-day confidence |
| Pad reliance may reduce | A portion of patients use fewer continence products after treatment |
| Short-term results may last | Follow-up suggests benefits can continue for months in some cases |
In clinic, the main question is not whether improvement is possible. It is who is most likely to improve, by how much, and for how long.
What results usually look like in real life
The best outcomes tend to be symptom reduction rather than complete resolution. A patient may go from leaking several times a week to occasional leakage, or from using multiple pads a day to fewer. For many people, that is a meaningful gain. It can make outings easier, reduce urgency around toilet access, and improve confidence with exercise, social contact, or appointments.
Older Australians often ask a very practical question. Will this treatment get me dry? The honest answer is that some people get substantial improvement, but a full cure is not a fair expectation to set from the current evidence.
That matters even more for people with mixed or complex continence issues. If pelvic floor weakness is only one part of the picture, Emsella may help one driver of leakage without fixing the whole problem.
Where the limits are
The published studies do not show that everyone responds. They also do not prove that outcomes in trial participants will match outcomes in frail older adults, people with significant mobility impairment, or NDIS participants whose bladder symptoms sit alongside disability, transfer difficulty, cognition changes, prolapse, constipation, or neurological disease.
I urge caution regarding marketing claims. A treatment can be useful and still have limits.
A balanced clinical view is usually this:
- For stress urinary incontinence, or mixed symptoms with a clear weakness component, Emsella may be a reasonable adjunct treatment.
- For older adults with several contributors to incontinence, results are often more modest and need to be judged against comfort, transport, transfer safety, and the effort of attending repeated sessions.
- For NDIS participants, the chair may fit into a broader continence strategy, but it should not replace assessment of functional barriers, toileting setup, carer support, skin protection, bowel management, and equipment needs.
Symptom improvement is a good outcome. Within a continence care plan, that can still be worthwhile even when pads, scheduled toileting, pelvic floor rehabilitation, medication review, or other supports remain part of the plan.
Determining If You Are a Good Candidate
Suitability starts with matching the treatment to the likely cause. That sounds obvious, but it's where many people get led astray by generic marketing.
People most likely to benefit
Emsella chair treatment is generally most relevant for people with stress urinary incontinence or mixed urinary symptoms where pelvic floor weakness appears to be an important driver. It can also be a conservative option for people with mild prolapse or for those who are poor surgical candidates, as noted in the peer-reviewed HIFEM study referenced earlier.
A reasonable candidate often has a pattern like this:
- Leakage with effort such as coughing, laughing, lifting, or exercise.
- Pelvic floor weakness after childbirth or ageing, where muscle support is likely reduced.
- A desire to avoid invasive care and try a conservative option first.
Men may also be considered in some settings if pelvic floor weakness is part of the issue, but that still needs individual assessment rather than assumption.
When caution matters more than convenience
The chair's convenience can make people overlook practical barriers. For older Australians and people with disability, suitability isn't only about the bladder. It's also about whether the person can safely transfer onto the chair, maintain positioning, tolerate the sensation, communicate discomfort, and attend repeated appointments.
A broader review is especially important when leakage may be driven by factors such as:
- Functional barriers like slow mobility, poor hand function, or difficulty reaching the toilet in time
- Medication or bowel factors such as constipation, sedation, or fluid-related patterns
- Complex neurological or cognitive issues where pelvic floor strengthening alone may not address the main problem
A short chair session can look simple on paper. In practice, some people need continence products, prompted toileting, bowel management, skin protection, transfer support, or home-based environmental changes more urgently than they need a device.
If you're considering Emsella, ask for a clinician to decide whether your leakage is primarily muscle weakness, bladder overactivity, functional incontinence, mixed causes, or something else. That classification matters more than the sales brochure.
The Emsella Treatment Process Explained
A lot of anxiety comes from not knowing what will happen. The process itself is straightforward, but the lead-up should still be clinical rather than cosmetic.
What happens before you sit on the chair
A proper start is an assessment conversation. The clinician should ask about your symptoms, medical history, medications, bowel habits, prolapse symptoms, goals, and any safety concerns. They should also consider whether Emsella is the right treatment, or only one possible option among several.
Once suitability is clear, the physical setup is simple.
You stay fully clothed and sit on the chair while the machine is positioned to target the pelvic floor area. This is one reason people often find it more approachable than internal treatments or procedures that involve undressing.
For a visual overview of what the setup and treatment style look like, this short video can help:
What a session feels like
The commonly described sensation is a strong but tolerable pelvic floor contraction with tingling or pulsing. It shouldn't feel like a sharp painful procedure. The sensation is often described as unusual rather than distressing, especially in the first session.
The treatment course often follows a regular schedule rather than a one-off visit. In the published device summaries noted earlier, outcomes were reported after 6 treatments. In practical terms, clinics often organise a short series rather than isolated bookings.
Here's the patient experience in plain terms:
- You arrive and are positioned on the chair.
- The intensity is adjusted so the contractions are effective but manageable.
- You feel rhythmic pelvic floor activity during the session.
- You stand up afterwards and go home, with no recovery period needed.
Because there's no downtime, many people return straight to work, errands, or home responsibilities. That convenience is real. The more important issue is whether the treatment series is worth committing to in light of your underlying diagnosis and likely benefit.
Cost and Funding Considerations in Australia
A common scenario in clinic is this. Someone hears about Emsella, feels hopeful for the first time in months, then asks whether Medicare or the NDIS will cover it. The answer is often frustratingly unclear.
Private payment and realistic expectations
In Australia, Emsella is usually offered as a private service. Fees vary between clinics, and the total cost can change depending on whether the provider charges separately for the initial review, sells treatment as a package, or includes follow-up in the quoted price.
Ask for the full cost in writing before you book.
A useful quote should set out:
- The cost of the initial assessment
- The number of sessions recommended
- Why that treatment course has been suggested for your type of leakage
- Any review or follow-up appointments included
- What the clinic recommends if improvement is limited or absent
That last point matters. Some people do notice worthwhile improvement. Others get only partial benefit, especially if leakage is linked to more than pelvic floor weakness alone. For older Australians and NDIS participants, bladder or bowel symptoms may also be affected by mobility limits, transfers, cognition, constipation, medication effects, prostate history, prolapse, or difficulty getting to the toilet in time. In those cases, an expensive device-based treatment may still have a role, but it should sit inside a clearly explained treatment plan rather than replacing simpler measures that may offer better value.
Medicare, NDIS and aged care questions
For Medicare, the safest starting assumption is private payment unless a provider has explained a specific rebate pathway in writing. It also helps to separate the components of care. A GP review, continence assessment, or pelvic floor physiotherapy may be funded in some circumstances. That does not mean a branded chair treatment itself is covered.
NDIS funding takes more preparation. Continence needs are common in disability support, but funding usually depends on the clinical reasoning, the participant's goals, and whether this option can be justified against other approaches that are lower cost or better established. That is a practical funding question, not only a treatment question.
If Emsella is being considered for an NDIS participant, these documents usually help:
| What helps your funding case | Why it matters |
|---|---|
| A continence assessment | Identifies the likely causes of leakage and whether pelvic floor stimulation is a reasonable fit |
| Evidence of day-to-day impact | Shows how symptoms affect safety, dignity, community access, carer support, or independence |
| Clear clinician notes | Explains why this option is being considered, what alternatives have been tried, and what outcome is being measured |
For older people using aged care services, access is often shaped by the provider's service model, local referral options, and the treating clinician's recommendation. There is rarely a simple item number that neatly covers everything. That is why I advise clients to ask two direct questions before committing. What exactly am I paying for, and how will we judge whether it has been worth it?
Why a Continence Assessment Should Be Your First Step
A common situation looks like this. Someone hears that the Emsella chair can help with leakage, books a package, and only later finds out the main problem was constipation, poor mobility to the toilet, medication effects, or a bladder condition that needed a different approach first.
That is why I advise starting with assessment. Emsella may suit some people, but continence care works best when the cause of leakage is clarified before money and effort go into a device-based treatment.
What an assessment looks for
A continence assessment answers a different clinical question. It looks at why leakage is happening, what risks sit around it, and which parts of the problem are changeable.
For older Australians and NDIS participants, that matters even more because leakage is often driven by several factors at once. A skilled review may look at bladder and bowel patterns, fluid intake, urgency, constipation, skin risk, medication effects, mobility, transfers, cognition, communication, pain, toilet access, clothing, carer support, and the timing of accidents.
Sometimes the assessment shows that pelvic floor stimulation is a reasonable option. Sometimes it shows that another starting point is more likely to help, such as:
- Bladder or bowel routine changes, if urgency, constipation, or poor timing is contributing
- Pelvic floor physiotherapy or guided exercise, if the person can participate actively and correctly
- Toileting access changes, including prompts, mobility aids, transfer planning, or easier clothing
- Containment products and skin protection, if the immediate concern is breakdown risk or unreliable toilet access
Nursing Assessment Australia provides continence assessments for NDIS and aged care contexts. That can be relevant when the main need is to document causes, risks, and practical management options before choosing a treatment path.
Why this matters for older Australians and NDIS participants
Older clients and people living with disability are often poorly served by one-size-fits-all marketing. A frail older person with arthritis, nocturia, slow transfers, and constipation does not have the same problem as someone with straightforward stress urinary leakage. An NDIS participant with communication difficulties, sensory issues, or neurogenic bladder may need a very different plan again.
The right option has to match the cause, the person's function, and the setting they live in.
A thorough assessment helps sort Emsella into the right category. It may be a good fit. It may be an adjunct to other treatment. It may be the wrong tool altogether. That clarity matters, especially when budgets are tight and travel, fatigue, support workers, or transport already make treatment harder to sustain.
Used carefully, Emsella can have a place in continence care. Used without proper assessment, it can become another expensive detour in a problem that already affects dignity, routine, and independence.